Impact of Dose Tapering of Tumor Necrosis Factor Inhibitor on Radiographic Progression in Ankylosing Spondylitis.
To investigate the impact of dose reduction of tumor necrosis factor inhibitor (TNFi) on radiographic progression in ankylosing spondylitis (AS).One hundred and sixty-five patients treated with etanercept or adalimumab were selected from a consecutive single-center observational cohort based on the...
Main Authors: | Jun Won Park, Hyun Mi Kwon, Jin Kyun Park, Ja-Young Choi, Eun Bong Lee, Yeong Wook Song, Eun Young Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5199008?pdf=render |
Similar Items
-
Association between changes in serum alkaline phosphatase levels and radiographic progression in ankylosing spondylitis
by: Tae-Hwan Kim, et al.
Published: (2023-06-01) -
The impact of smoking status on radiographic progression in patients with ankylosing spondylitis on anti-tumor necrosis factor treatment
by: Bora Nam, et al.
Published: (2022-10-01) -
Prediction of radiographic progression pattern in patients with ankylosing spondylitis using group-based trajectory modeling and decision trees
by: Juyeon Kang, et al.
Published: (2022-10-01) -
High Baseline Neutrophil-to-Lymphocyte Ratio Could Serve as a Biomarker for Tumor Necrosis Factor-Alpha Blockers and Their Discontinuation in Patients with Ankylosing Spondylitis
by: Dong-Hyuk Moon, et al.
Published: (2023-03-01) -
Primary Biliary Cholangitis with Ankylosing Spondylitis
by: Young Mi Hong, et al.
Published: (2022-06-01)